Abstract

ObjectiveTo evaluate the changes of plasma B-type natriuretic peptide(BNP) levels after high-pressure post-dilation following coronary stent deployment.MethodsA total of 173 patients undergoing percutaneous coronary intervention for the left anterior descending artery were enrolled into the study. All patients were divided into two groups: the conventional group and the post-dilation group. The plasma BNP, troponin I(TnI), myocardial band isoenzyme of creatine kinase(CK-MB) levels and the serum high sensitive C-reactive protein(hs-CRP) levels immediately before and 24 hours after the interventional procedures were compared between the two groups.ResultsThere were no significant differences between the two groups in terms of clinical features, clinical and biochemical parameters, stent parameters, pre-procedural plasma BNP and TnI levels, pre-procedural serum hs-CRP levels, as well as pre- and post-procedural CK-MB levels (all P>0.05). In the conventional group, post-procedural plasma BNP levels were significantly reduced when compared with the pre-procedural levels, median(25th,75th) were 32.5 ng/L(15.0,52.4) vs. 37.7 ng/L(18.2,67.3), P = 0.001. In the post-dilation group, post-procedural plasma BNP levels were significantly increased when compared with the pre-procedural levels, median(25th,75th) were 53.5 ng/L(29.6,82.8) vs. 44.2 ng/L(17.15,70.7), P<0.0001. Post-procedural plasma TnI levels were also significantly increased when compared with the pre-procedural levels in both groups, median(25th,75th) were 0.02 ng/L(0.01,0.08) vs. 0.01 ng/L(0.01,0.01), 0.05 ng/L(0.01,0.35) vs. 0.01 ng/L(0.01,0.01), respectively, P<0.0001, so were the serum hs-CRP levels, median(25th,75th) were 3.3 mg/L(2.4,4.7) vs. 2.2 mg/L(1.4,3.3), 4.2 mg/L(3.175,5.825) vs. 2.3 mg/L(1.45,3.6), respectively, P<0.0001. Post-procedural plasma BNP, TnI and serum hs-CRP levels in the post-dilation group were significantly higher than those in the conventional group(all P<0.0001).ConclusionHigh-pressure post-dilation following coronary stent deployment resulted in a significant increase of plasma BNP levels, as well as plasma TnI levels and serum hs-CRP levels, which may be related to myocardial perfusion, more myocardial injury and more inflammation.

Highlights

  • With the advances in cardiovascular interventional technology and materials, percutaneous coronary intervention plays an increasingly important role in the treatment of coronary heart diseases

  • Previous studies have shown that postdilation can improve the stent expansion and reduce the risk of stent thrombosis. This technology has been widely used in coronary interventional procedures [1],[2],[3],[4]

  • We found that in our clinical practice, some patients undergoing highpressure balloon post-dilation suffered from some symptoms such as mild chest discomfort or short of breath shortly after the procedure

Read more

Summary

Introduction

With the advances in cardiovascular interventional technology and materials, percutaneous coronary intervention plays an increasingly important role in the treatment of coronary heart diseases. Previous studies have shown that postdilation can improve the stent expansion and reduce the risk of stent thrombosis. This technology has been widely used in coronary interventional procedures [1],[2],[3],[4]. We found that in our clinical practice, some patients undergoing highpressure balloon post-dilation suffered from some symptoms such as mild chest discomfort or short of breath shortly after the procedure. Whether such symptoms meant cardiac dysfunction was uncertain. A correct evaluation of the relationship between post-dilation and cardiac function will

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call